Skip to content
ASGLY

AGC Inc.

AGC Inc. Q1 FY2026 earnings call

May 12, 2026 · fiscal period ended 2026-03

EPS · actual vs est

$107.73 /

Revenue · actual vs est

$537.97B / $486.07BBeat +10.7%
Ask about this call

Summary

Generated 2026-05-12

Management highlights

Overall Fiscal 26 Q1 Results

  • Consolidated net sales increased 38.4 billion yen year-on-year to 538 billion yen. Growth was driven by yen depreciation, higher shipments of essential chemicals to Southeast Asia, and pricing policy effects in European architectural glass, which offset declines including lower essential chemical prices in Southeast Asia and lower architectural glass shipments in Europe and the Americas.
  • Consolidated operating profit increased 12.6 billion yen year-on-year to 38.5 billion yen. In addition to net sales growth, improved profitability in life science and lower natural gas prices in Europe contributed to the gain. Profit before tax rose 18 billion yen to 35 billion yen, boosted by both operating profit improvement and foreign exchange gains; profit attributable to parent owners increased 16.2 billion yen to 22.8 billion yen.

Balance Sheet & Cash Flow

  • Total assets reached 2.9955 trillion yen, an increase of 45.5 billion yen from the end of last fiscal year, with 5.9 billion yen of the increase from foreign exchange fluctuations. The debt-to-equity ratio is 0.41.
  • Quarterly operating cash flow was positive 42.6 billion yen, investment cash flow was negative 59.7 billion yen, resulting in negative free cash flow of 17.1 billion yen. The negative investment cash flow stemmed from scheduled accounts payable payments, even with lower capital expenditures year-on-year.
  • Q1 capital expenditures totaled 44.1 billion yen (down 5.5 billion yen year-on-year), depreciation was 48.1 billion yen, and R&D expenses totaled 13.9 billion yen.

Operational Updates

  • Life Science: Fixed cost reduction measures (including the closure of the Colorado biopharmaceutical CDMO site) have delivered realized savings; contract order volume and productivity at the Copenhagen site improved quarter-over-quarter. Negotiations for the planned sale of the Colorado site continue, with all personnel costs already eliminated, leaving only depreciation and administrative expenses.
  • Chemical: The expanded essential chemicals production facility in Thailand is currently ramping up operation, and is expected to operate at high utilization rates starting in Q2. Procurement for the segment's Southeast Asia operations is diversified away from Middle East sources: Thailand sources ethylene from domestic natural gas, and Indonesia sources from North America.
  • Electronics: EUV mask blank shipments are in recovery; demand for semiconductor-related materials and optoelectronics materials grew in Q1. Strong demand is expected for CCL (copper clad laminate) tied to AI server and high-speed communication markets for the full fiscal year.
View in transcript ↓

Segment performance

  1. Architectural glass: Net sales increased 8 billion yen to 112 billion yen, contributing 20.8% of total consolidated net sales. Operating profit rose 5.6 billion yen to 4.7 billion yen, contributing 12.2% of total consolidated operating profit. Approximately 10% of operating profit comes from Asia, and 90% comes from Europe and the Americas.
  2. Automotive: Net sales increased 8.9 billion yen to 137.6 billion yen, contributing 25.6% of total consolidated net sales. Operating profit rose 1 billion yen to 8.6 billion yen, contributing 22.3% of total consolidated operating profit.
  3. Electronics: Net sales increased 3.6 billion yen to 90.3 billion yen, contributing 16.8% of total consolidated net sales. Operating profit decreased 1.8 billion yen to 12.3 billion yen, contributing 31.9% of total consolidated operating profit. Approximately 30% of operating profit comes from display, and 70% comes from electronic materials.
  4. Chemical: Net sales increased 13.1 billion yen to 157.2 billion yen, contributing 29.2% of total consolidated net sales. Operating profit rose 4.1 billion yen to 15.2 billion yen, contributing 39.5% of total consolidated operating profit. 80% of operating profit comes from Integrated Chemicals, and 20% comes from Essential Chemicals Southeast Asia.
  5. Life Science: Net sales increased 4.6 billion yen to 35.6 billion yen, contributing 6.6% of total consolidated net sales. Operating profit improved by 2.8 billion yen, resulting in an operating loss of 3.3 billion yen.
  6. Strategic Businesses: Overall net sales increased 13.2 billion yen to 130.6 billion yen, and operating profit rose 7.6 billion yen to 18.5 billion yen, accounting for 48% of total consolidated operating profit.
View in transcript ↓

Guidance

  • Full year 26 consolidated net sales and operating profit guidance remains unchanged from the February announcement. The full year crude oil price assumption was revised upward from $70 per barrel to $100 per barrel, but management expects all related cost increases to be fully offset by existing countermeasures.
  • Architectural glass: Shipments are expected to rise in Asia due to demand recovery in Thailand and Indonesia. Recovery in shipments will be limited in Europe and the Americas due to ongoing regional economic downturn. Management will continue price adjustment and productivity improvement measures to offset potential cost increases from higher fuel prices.
  • Automotive: Full year shipments are expected to decline due to lower global automotive production volumes and reduced exports to the Middle East. Management will focus on product mix improvement, productivity enhancement, and price adjustments to offset rising fuel costs.
  • Electronics: LCD glass substrate shipments are expected to see a slight annual decline, with ongoing profitability improvement measures. Semiconductor-related materials (including EUV mask blanks) are expected to see increased full year shipments, while optoelectronics materials shipments are expected to remain flat quarter-over-quarter.
  • Chemical: Integrated chemicals will see increased shipments of electronics-grade products; essential chemicals Southeast Asia will see higher shipments as the expanded Thailand facility reaches full operation. Management will secure non-Middle East raw material sources and pass higher raw material/fuel costs through to selling prices.
  • Life Science: Sales of small molecule and biopharmaceutical CDMO are expected to increase, with improved productivity from newly expanded facilities. Closure of the Colorado facility is expected to significantly reduce the segment's full year net loss.
  • Strategic businesses: The four-year strategic outlook is maintained, projecting full year 26 net sales of 560 billion yen (up 58.5 billion yen year-on-year) and operating profit of 80 billion yen (up 21.3 billion yen year-on-year). Capital expenditure, depreciation, and R&D expense forecasts remain unchanged, with full year capital expenditures planned to decline 61.3 billion yen year-on-year.
  • Q2 26 outlook: Management expects consolidated net sales and operating profit to decline quarter-over-quarter, driven by normal seasonal shipment declines in automotive and electronics. Chemical net sales will increase quarter-over-quarter, but operating profit will decline due to the absence of Q1's one-time gains in Integrated Chemicals.
View in transcript ↓

Risks

  • Geopolitical risks from ongoing Middle East developments: Potential negative impacts include raw material/fuel procurement disruptions, higher commodity prices, reduced sales volumes of PVC, caustic soda, and automotive glass due to production adjustments and lower exports to the Middle East. Management estimates full year negative impacts of approximately 10 billion yen to raw material/fuel costs and 10 billion yen to sales volume, but expects to fully offset these impacts through countermeasures.
  • Downside demand risk: Passing higher raw material and fuel costs through to selling prices could dampen demand in a weak global economic environment, with significant regional differences in demand sensitivity that require careful monitoring.
  • Segment-specific risks: Higher crude oil prices increase input costs for architectural glass, automotive, and chemical segments; electronics segment profitability faces pressure from high manufacturing costs and weak demand for M4 displays.
View in transcript ↓

Q&A highlights

Q: How did Q1 results compare to management's initial expectations by segment? / A: Net sales for automotive and electronics beat expectations, while operating profit for electronics and chemicals beat expectations. Automotive outperformed due to better-than-expected product mix and higher shipments across Japan, Europe, and North America. Electronics outperformed due to higher-than-expected shipments of optoelectronic and semiconductor-related components. Chemicals outperformance was driven by one-time gains from consolidation adjustments and accounting closing changes.

Q: You raised the full year crude oil assumption from $70 to $100 per barrel but kept full year earnings guidance unchanged. How can higher crude prices be offset? / A: Higher crude prices raise costs for ethylene, propylene, and other inputs, which increases cost pressure for the architectural glass, automotive, and chemical segments. There are also additional risks of production adjustments and demand declines tied to Middle East supply disruptions. Management expects all increased costs and negative impacts will be fully offset through procurement diversification, production adjustments, internal cost reduction, and targeted selling price adjustments.

Q: Can you explain the one-time drivers of Q1 chemical segment upside? / A: The upside comes from three main factors: improved production costs, inventory adjustment gains from rising commodity prices, and one-time gains from deconsolidating low-contribution AGC Group subsidiaries, which are now accounted for under the equity method. The deconsolidation created an early double-digit billion yen one-time positive impact in Q1. Year-over-year profit growth also reflects progress in broad cost cutting across the segment.

Q: What is your outlook for semiconductor-related materials demand this fiscal year? / A: AGC expects global shipments of semiconductor-related products to increase year-over-year in fiscal 26. EUV mask blanks and other AGC semiconductor materials are therefore expected to see higher shipments compared to the previous year. Overall demand for EUV mask blanks is healthy and flat-to-positive compared to the prior term, though management cannot comment on specific customer demand levels.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$107.73
Revenue$537.97B$486.07B+10.7%

Transcript

May 12, 2026

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.